TITLE:
A Study of MK0217A and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)

CONDITION:
Osteoporosis

INTERVENTION:
MK0217A, alendronate sodium (+) cholecalciferol / Duration of Treatment: 24 weeks

SUMMARY:

      The purpose of this study is to test the safety, tolerability, and effectiveness of an
      investigational drug and dietary supplement to reduce the risk of vitamin D insufficiency
      and deficiency during treatment of osteoporosis in men and postmenopausal women.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 40 Years to 90 Years
Criteria:

        Inclusion Criteria:

          -  Men or postmenopausal women who are osteoporotic

        Exclusion Criteria:

          -  Vitamin D deficiency

          -  Other disease of bone or mineral metabolism

          -  Digestive disease causing malabsorption

          -  Other medical conditions that are not adequately treated
      
